Nano-bio enabled diagnostic devices for oral healthcare
Lead Participant:
OJ-BIO LIMITED
Abstract
Gum disease is a major healthcare problem. This has a huge economic impact, with an estimated cost to the UK of £2.78 Billion in 2008. This project consortium will deliver a device that will enable patients and dentists to diagnose and monitor gum disease accurately, simply and cost effectively, by identifying signs of the disease in saliva. It brings together a multi-disciplinary effort of UK excellence in nanoscale science; electronic biosensor company, OJ-Bio Ltd, nanobiotechnology company, Orla Protein Technologies Ltd, and clinical excellence through the world leading Dental Research Facility at Newcastle University.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
OJ-BIO LIMITED | £468,057 | £ 234,029 |
  | ||
Participant |
||
ORLA PROTEIN TECHNOLOGIES LIMITED | £203,410 | £ 101,705 |
UNIVERSITY OF NEWCASTLE |
People |
ORCID iD |
Dale Athey (Project Manager) |